Shopping News / Articles
Lipid Nanoparticle Market to Cross US$ 1. 85 Billion by 2033 as m RNA Therapies and Precision Medicine Accelerate
2+ hour, 32+ min ago (1156+ words) Lipid nanoparticles are no longer limited to vaccine applications. They are now being widely explored for cancer treatment, autoimmune disorders, rare diseases, neurological conditions, and advanced drug delivery systems. As pharmaceutical companies continue to pursue more effective and personalized treatments,…...
Scientists Have Found a Way To Feed Immune Cells Without Fueling Cancer
2+ hour, 49+ min ago (322+ words) UCLA researchers gave T cells a protected supply of sugar, allowing them to attack solid tumors more effectively. UCLA researchers have developed a way to give immune cells a fuel supply that tumors cannot take away, sharply improving how well…...
How endotoxin-free proteins reduce hidden risks in cancer and immunology research
2+ hour, 23+ min ago (1277+ words) Endotoxin, a lipopolysaccharide (LPS) originating from the outer membrane of Gram-negative bacteria, remains one of the most common and difficult contaminants in recombinant protein preparations, particularly those derived from E. coli expression systems or prokaryotic plasmids. Due to its high immunostimulatory…...
ASCO, pancreatic cancer, GSK, hep B: Readout Newsletter
3+ hour, 1+ min ago (166+ words) Meghana Keshavan is a biotech correspondent at STAT and co-writer of The Readout newsletter. She joined STAT in 2016. She has written about the life sciences industry for more than a decade. Before that, she worked for news outlets like Thomson…...
Sapu Nano Unveils Progress in Deciparticle" Nanomedicine Platform and AI-Driven Oncology Development at BIO 2026
3+ hour, 7+ min ago (192+ words) SAN DIEGO, Calif. , May 28, 2026 (GLOBE NEWSWIRE) -- via IBN -- Sapu Nano and Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") today announced that Vuong Trieu, Chief Executive Officer, will present the Company's Deciparticle" nanomedicine platform at the BIO International Convention 2026 in San…...
Researchers test noninvasive cancer treatment to trigger body's immune defenses
1+ day, 2+ hour ago (715+ words) The search feature within the content management system themes has options for searching the site you are currently on (default), searching all Virginia Tech websites, or searching for people directory information. Search results will appear in the All tab for…...
Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development
4+ hour, 32+ min ago (756+ words) The Manila Times Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development Collaboration Leverages Prior Andes, Marburg and Ebola Virus Research and Dyadic's C1 Platform Capabilities for Fast, Scalable Biologic Production JUPITER, Fla. , May 28, 2026 (GLOBE NEWSWIRE) -- Dyadic International,…...
The never-ending puzzle: whatimmunology keeps teaching me
11+ hour, 41+ min ago (908+ words) If you would like to give to a specific research program or support the work of a particular researcher, contact our fundraising team today. The immune system is one of the most complex systems in biology. The strange thing is…...
Redefining the Oncology Drug Discovery and Development Ecosystem
20+ hour, 29+ min ago (660+ words) AACR Annual Meeting News: Read the Latest Session Recaps from the Official News Website Home > About the AACR > Newsroom > Meeting News > Redefining the Oncology Drug Discovery and Development Ecosystem This summer, the American Association for Cancer Research (AACR) will host…...
Physiomics Demonstrates Hantavirus Translational Modelling Capability
9+ hour, 21+ min ago (251+ words) Why Physiomics Could Be Entering A New Phase Of Commercial Growth The framework illustrates how Physiomics can integrate multiple evidence layers into a coherent translational workflow, linking: " in vitro antiviral screening; " mechanistic PK/PD viral dynamics; and The modelling workflow…...
Shopping
Please enter a search for detailed shopping results.